泰凌医药
港股通 官网
( 01011.hk)
市盈率-6.92市净率-1.73股息率0%上市时间2011-04-20股价0.78港币涨跌幅-3.70%成交金额16.73万港币换手率0.03%市值5.26亿港币H股市值5.26亿港币总股本6.74亿H股本6.74亿每手股数1.00万上市至今年化投资收益率-22.94%
所属三级行业药品 (恒生) 市盈率31.96市净率3.09股息率1.06%恒生:医疗保健业药品及生物科技药品
备注 (0): 双击编辑备注
发表讨论

泰凌医药(01011) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1吳銘軍Independent Non Executive Director - A/F2023-01-19--
2潘飛Independent Non Executive Director - A/F2020-03-202023-01-19
3趙玉彪Independent Non Executive Director2019-12-31--
4王飛Executive Director2019-01-102019-11-29
5嚴弘Independent Non Executive Director2018-06-152020-03-20
6婁健穎Non Executive Director2017-07-312019-11-29
7余梓山Independent Non Executive Director2017-06-29--
8葛劍秋Non Executive Director2016-05-312017-07-31
9吳為忠Executive Director2015-03-202022-08-24
10錢余Executive Director2015-02-01--
11洪亮Non Executive Director2012-09-302014-09-18
12王凡Non Executive Director2012-09-132015-03-20
13羅卓堅Non Executive Director2011-03-252012-09-30
14徐立之Independent Non Executive Director2010-04-012018-06-15
15吳鑯Executive DirectorChairman, CEO2010-03-01--
16錢唯Non Executive Director2010-03-01--
17辛定華Independent Non Executive Director - A/F2010-03-012019-12-31
18唐裕年Independent Non Executive Director2010-03-012017-06-29
19錢余Non Executive Director2010-03-012015-02-01
20吳育強Executive Director2010-03-012012-07-01